Linda Yaccarino Appointed CEO of eMed Population Health

In August 2025, eMed Population Health announced the appointment of Linda Yaccarino, formerly CEO of X, as its new Chief Executive Officer. A highly sought-after leader, she is credited with guiding the company toward achieving its mission of making “safe, effective, and sustainable chronic care accessible directly through an all‑in‑one, digital‑first experience”.

With deep experience in negotiating strategic partnerships and leading transformational change, including her previous role overseeing global advertising at NBCUniversal, Yaccarino's leadership marks a pivotal chapter for eMed, as it scales offerings like at-home diagnostics, proctor‑led screenings, physician-guided prescribing, and ongoing adherence support for patients using GLP‑1 and GIP therapies. 

Her appointment comes shortly after stepping down from X in July 2025, amid internal shifts following X’s merger with Musk’s xAI and arising tensions over advertising relations. At eMed, Yaccarino sees an opportunity to “combine technology, lifestyle, and data in a new powerful way through digital channels that impact consumers directly in ways that have never been done before,” signaling a bold new vision for healthcare innovation.